To: scouter
No. There is a medication, ZMapp, that was given to a VERY FEW patients. Some of those patients have recovered. But up to 40% of patients recover anyway, without ZMapp, so there is no way at all to attribute their recovery to ZMapp.
“Up to” 40%. Apparently 100% of those given ZMapp recover. Of course, the numbers are too low to be empirical, so maybe they should broaden it. I'd like to see them issue it to the people in that peninsula that has been quarantined. Why don't they?
17 posted on
08/21/2014 9:35:32 AM PDT by
cuban leaf
(The US will not survive the obama presidency. The world may not either.)
To: cuban leaf
Apparently 100% of those given ZMapp recover.Actually, at least one patient who was given ZMapp has died, and the very few others have not yet recovered.
22 posted on
08/21/2014 9:44:44 AM PDT by
scouter
To: cuban leaf
They can’t administer a drug whose supply is depleted. There were only a few experimental doses, and they were used up.
More is being manufactured, but it takes time.
Also consider that an experimental drug can be very dangerous, even deadly. When you’re dying anyway, giving informed consent is a no-brainer. It is apparently not a preventive, only effective after symptoms appear, so the patient receiving a dose would have to be cogent enough to agree in writing to accept the risk.
24 posted on
08/21/2014 9:48:19 AM PDT by
Jedidah
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson